Makary Discusses Expedited Rare Disease Approvals Pathway, ‘Public Distrust’ in New Interview

Makary Discusses Expedited Rare Disease Approvals Pathway, ‘Public Distrust’ in New Interview

Source: 
BioSpace
snippet: 

In an interview with former Fox News journalist Megyn Kelly, FDA Commissioner Marty Makary introduced a new mechanism-driven pathway that could be leveraged by rare disease therapies while saying that autism could potentially be driven by certain environmental factors.